American Century Companies Inc. Increases Stock Holdings in Solventum Co. (NYSE:SOLV)

American Century Companies Inc. grew its holdings in shares of Solventum Co. (NYSE:SOLV) by 43.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 146,608 shares of the company’s stock after purchasing an additional 44,251 shares during the period. American Century Companies Inc. owned about 0.08% of Solventum worth $9,685,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Modus Advisors LLC acquired a new stake in shares of Solventum in the fourth quarter valued at $25,000. Stonebridge Financial Group LLC purchased a new stake in Solventum during the 4th quarter worth about $26,000. Crews Bank & Trust acquired a new stake in Solventum in the 4th quarter valued at about $32,000. Synergy Asset Management LLC purchased a new position in shares of Solventum in the 4th quarter valued at about $35,000. Finally, Spire Wealth Management acquired a new position in shares of Solventum during the fourth quarter worth about $37,000.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on SOLV. Piper Sandler raised their target price on shares of Solventum from $75.00 to $84.00 and gave the company a “neutral” rating in a report on Friday, February 28th. Mizuho raised their price objective on shares of Solventum from $70.00 to $82.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Bank of America lifted their price objective on shares of Solventum from $80.00 to $85.00 and gave the stock a “neutral” rating in a research report on Wednesday, February 26th. Morgan Stanley increased their target price on Solventum from $73.00 to $80.00 and gave the company an “equal weight” rating in a report on Wednesday, March 5th. Finally, Wells Fargo & Company lifted their price target on Solventum from $73.00 to $75.00 and gave the stock an “equal weight” rating in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat.com, Solventum currently has an average rating of “Hold” and a consensus target price of $79.86.

Solventum Price Performance

Shares of SOLV opened at $76.54 on Thursday. The company has a debt-to-equity ratio of 2.45, a current ratio of 1.15 and a quick ratio of 0.83. Solventum Co. has a 1-year low of $47.16 and a 1-year high of $85.92. The stock has a market cap of $13.24 billion and a PE ratio of 27.83. The firm has a fifty day moving average price of $75.66 and a 200 day moving average price of $72.00.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.